HEADER IMMUNE SYSTEM/INHIBITOR 06-JUN-18 6DN8 TITLE SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 2 COMPLEXED WITH (GZJ) TITLE 2 VDINNN(CY3) CYCLIC PEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 4; COMPND 3 CHAIN: A, C, E; COMPND 4 SYNONYM: SSB-4; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: (GZJ)VDINNN(CY3) CYCLIC PEPTIDE INHIBITOR; COMPND 8 CHAIN: B, D, F; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SPSB4, SSB4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: K12; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS PROTEASOMAL DEGRADATION, NITRIC OXIDE, INHIBITOR, IMMUNE SYSTEM, KEYWDS 2 IMMUNE SYSTEM-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.H.P.LAW,T.T.CARADOC-DAVIES,R.S.NORTON REVDAT 3 13-APR-22 6DN8 1 COMPND SOURCE REMARK DBREF REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 08-JAN-20 6DN8 1 REMARK REVDAT 1 17-APR-19 6DN8 0 JRNL AUTH M.M.SADEK,N.BARLOW,E.W.W.LEUNG,B.J.WILLIAMS-NOONAN,B.K.YAP, JRNL AUTH 2 F.M.SHARIFF,T.T.CARADOC-DAVIES,S.E.NICHOLSON,D.K.CHALMERS, JRNL AUTH 3 P.E.THOMPSON,R.H.P.LAW,R.S.NORTON JRNL TITL A CYCLIC PEPTIDE INHIBITOR OF THE INOS-SPSB PROTEIN-PROTEIN JRNL TITL 2 INTERACTION AS A POTENTIAL ANTI-INFECTIVE AGENT. JRNL REF ACS CHEM. BIOL. V. 13 2930 2018 JRNL REFN ESSN 1554-8937 JRNL PMID 30226743 JRNL DOI 10.1021/ACSCHEMBIO.8B00561 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 64787 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910 REMARK 3 FREE R VALUE TEST SET COUNT : 3178 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.79 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.91 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4690 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2542 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4468 REMARK 3 BIN R VALUE (WORKING SET) : 0.2525 REMARK 3 BIN FREE R VALUE : 0.2892 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.73 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 222 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4734 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 519 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.51 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.39260 REMARK 3 B22 (A**2) : -6.06000 REMARK 3 B33 (A**2) : 0.66740 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.250 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.125 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.108 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.117 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.105 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4888 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6638 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1599 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 107 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 731 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4888 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 583 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6042 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.70 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.08 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 14.2229 129.1770 129.7980 REMARK 3 T TENSOR REMARK 3 T11: -0.1639 T22: -0.1341 REMARK 3 T33: -0.1456 T12: 0.0096 REMARK 3 T13: -0.0089 T23: -0.0213 REMARK 3 L TENSOR REMARK 3 L11: 0.2967 L22: 0.2900 REMARK 3 L33: 0.8212 L12: 0.3910 REMARK 3 L13: 0.0815 L23: 0.3398 REMARK 3 S TENSOR REMARK 3 S11: -0.0096 S12: 0.0483 S13: -0.0140 REMARK 3 S21: 0.0984 S22: 0.0227 S23: 0.0076 REMARK 3 S31: -0.0037 S32: 0.0722 S33: -0.0131 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { C|* } REMARK 3 ORIGIN FOR THE GROUP (A): -6.8501 104.1750 140.3030 REMARK 3 T TENSOR REMARK 3 T11: -0.0885 T22: -0.2034 REMARK 3 T33: -0.1457 T12: -0.0071 REMARK 3 T13: -0.0033 T23: -0.0235 REMARK 3 L TENSOR REMARK 3 L11: 0.2021 L22: 0.2420 REMARK 3 L33: 0.3631 L12: -0.1162 REMARK 3 L13: -0.1140 L23: 0.4107 REMARK 3 S TENSOR REMARK 3 S11: -0.0081 S12: 0.0104 S13: -0.0952 REMARK 3 S21: 0.1460 S22: 0.0026 S23: 0.0082 REMARK 3 S31: 0.0440 S32: 0.0230 S33: 0.0055 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { E|* } REMARK 3 ORIGIN FOR THE GROUP (A): -18.5859 128.1400 162.5800 REMARK 3 T TENSOR REMARK 3 T11: -0.1286 T22: -0.1267 REMARK 3 T33: -0.1545 T12: -0.0264 REMARK 3 T13: -0.0063 T23: -0.0221 REMARK 3 L TENSOR REMARK 3 L11: 0.0217 L22: 0.2079 REMARK 3 L33: 1.2545 L12: -0.1270 REMARK 3 L13: -0.3333 L23: 0.2949 REMARK 3 S TENSOR REMARK 3 S11: 0.0256 S12: -0.0065 S13: -0.0315 REMARK 3 S21: -0.0898 S22: -0.0173 S23: -0.0266 REMARK 3 S31: 0.0878 S32: -0.1064 S33: -0.0083 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DN8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1000234594. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64838 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 45.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.700 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.82200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M NH4SO4, 0.1M NAAC, 25% PEG4,000, REMARK 280 PH 4.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.68500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.05000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.68500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 59.05000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE (GZJ)VDINNN(CY3) CYCLIC PEPTIDE INHIBITOR IS CYCLIC PEPTIDE, A REMARK 400 MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: (GZJ)VDINNN(CY3) CYCLIC PEPTIDE INHIBITOR REMARK 400 CHAIN: B, D, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 HIS A 10 REMARK 465 HIS A 11 REMARK 465 SER A 12 REMARK 465 SER A 13 REMARK 465 GLY A 14 REMARK 465 VAL A 15 REMARK 465 ASP A 16 REMARK 465 LEU A 17 REMARK 465 GLY A 18 REMARK 465 THR A 19 REMARK 465 GLU A 20 REMARK 465 ASN A 21 REMARK 465 LEU A 22 REMARK 465 TYR A 23 REMARK 465 PHE A 24 REMARK 465 GLN A 25 REMARK 465 SER A 26 REMARK 465 MET A 27 REMARK 465 GLY A 28 REMARK 465 ALA A 29 REMARK 465 GLU A 30 REMARK 465 PRO A 31 REMARK 465 GLY A 32 REMARK 465 GLY A 166 REMARK 465 PRO A 167 REMARK 465 ASP A 168 REMARK 465 GLU A 169 REMARK 465 ALA A 170 REMARK 465 GLU A 233 REMARK 465 MET C 5 REMARK 465 HIS C 6 REMARK 465 HIS C 7 REMARK 465 HIS C 8 REMARK 465 HIS C 9 REMARK 465 HIS C 10 REMARK 465 HIS C 11 REMARK 465 SER C 12 REMARK 465 SER C 13 REMARK 465 GLY C 14 REMARK 465 VAL C 15 REMARK 465 ASP C 16 REMARK 465 LEU C 17 REMARK 465 GLY C 18 REMARK 465 THR C 19 REMARK 465 GLU C 20 REMARK 465 ASN C 21 REMARK 465 LEU C 22 REMARK 465 TYR C 23 REMARK 465 PHE C 24 REMARK 465 GLN C 25 REMARK 465 SER C 26 REMARK 465 MET C 27 REMARK 465 GLY C 28 REMARK 465 ALA C 29 REMARK 465 GLU C 30 REMARK 465 PRO C 31 REMARK 465 GLY C 32 REMARK 465 ARG C 33 REMARK 465 PRO C 34 REMARK 465 GLU C 233 REMARK 465 MET E 5 REMARK 465 HIS E 6 REMARK 465 HIS E 7 REMARK 465 HIS E 8 REMARK 465 HIS E 9 REMARK 465 HIS E 10 REMARK 465 HIS E 11 REMARK 465 SER E 12 REMARK 465 SER E 13 REMARK 465 GLY E 14 REMARK 465 VAL E 15 REMARK 465 ASP E 16 REMARK 465 LEU E 17 REMARK 465 GLY E 18 REMARK 465 THR E 19 REMARK 465 GLU E 20 REMARK 465 ASN E 21 REMARK 465 LEU E 22 REMARK 465 TYR E 23 REMARK 465 PHE E 24 REMARK 465 GLN E 25 REMARK 465 SER E 26 REMARK 465 MET E 27 REMARK 465 GLY E 28 REMARK 465 ALA E 29 REMARK 465 GLU E 30 REMARK 465 PRO E 31 REMARK 465 GLY E 32 REMARK 465 LEU E 165 REMARK 465 GLY E 166 REMARK 465 PRO E 167 REMARK 465 ASP E 168 REMARK 465 GLU E 233 REMARK 465 GZJ F 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 164 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 165 CG CD1 CD2 REMARK 470 ARG C 107 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 154 CE NZ REMARK 470 ARG E 95 CD NE CZ NH1 NH2 REMARK 470 GLN E 156 CG CD OE1 NE2 REMARK 470 GLU E 169 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL B 2 C - N - CA ANGL. DEV. = 16.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN D 7 65.83 -111.06 REMARK 500 ASP E 136 -162.33 -128.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GZJ B 1 -15.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 C 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 C 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT E 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues CY3 B 101 and GZJ B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GZJ D 1 and VAL D 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide CY3 D 101 and ASN D REMARK 800 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues CY3 D 101 and GZJ D 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide CY3 F 101 and ASN F REMARK 800 7 DBREF 6DN8 A 28 233 UNP Q96A44 SPSB4_HUMAN 28 233 DBREF 6DN8 B 1 101 PDB 6DN8 6DN8 1 101 DBREF 6DN8 C 28 233 UNP Q96A44 SPSB4_HUMAN 28 233 DBREF 6DN8 D 1 101 PDB 6DN8 6DN8 1 101 DBREF 6DN8 E 28 233 UNP Q96A44 SPSB4_HUMAN 28 233 DBREF 6DN8 F 1 101 PDB 6DN8 6DN8 1 101 SEQADV 6DN8 MET A 5 UNP Q96A44 INITIATING METHIONINE SEQADV 6DN8 HIS A 6 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS A 7 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS A 8 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS A 9 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS A 10 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS A 11 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 SER A 12 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 SER A 13 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLY A 14 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 VAL A 15 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 ASP A 16 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 LEU A 17 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLY A 18 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 THR A 19 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLU A 20 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 ASN A 21 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 LEU A 22 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 TYR A 23 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 PHE A 24 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLN A 25 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 SER A 26 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 MET A 27 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 MET C 5 UNP Q96A44 INITIATING METHIONINE SEQADV 6DN8 HIS C 6 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS C 7 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS C 8 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS C 9 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS C 10 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS C 11 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 SER C 12 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 SER C 13 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLY C 14 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 VAL C 15 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 ASP C 16 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 LEU C 17 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLY C 18 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 THR C 19 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLU C 20 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 ASN C 21 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 LEU C 22 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 TYR C 23 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 PHE C 24 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLN C 25 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 SER C 26 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 MET C 27 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 MET E 5 UNP Q96A44 INITIATING METHIONINE SEQADV 6DN8 HIS E 6 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS E 7 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS E 8 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS E 9 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS E 10 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 HIS E 11 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 SER E 12 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 SER E 13 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLY E 14 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 VAL E 15 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 ASP E 16 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 LEU E 17 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLY E 18 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 THR E 19 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLU E 20 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 ASN E 21 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 LEU E 22 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 TYR E 23 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 PHE E 24 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 GLN E 25 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 SER E 26 UNP Q96A44 EXPRESSION TAG SEQADV 6DN8 MET E 27 UNP Q96A44 EXPRESSION TAG SEQRES 1 A 229 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 229 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLY ALA GLU SEQRES 3 A 229 PRO GLY ARG PRO ALA ARG LEU ASP GLN LEU LEU ASP MET SEQRES 4 A 229 PRO ALA ALA GLY LEU ALA VAL GLN LEU ARG HIS ALA TRP SEQRES 5 A 229 ASN PRO GLU ASP ARG SER LEU ASN VAL PHE VAL LYS ASP SEQRES 6 A 229 ASP ASP ARG LEU THR PHE HIS ARG HIS PRO VAL ALA GLN SEQRES 7 A 229 SER THR ASP GLY ILE ARG GLY LYS VAL GLY HIS ALA ARG SEQRES 8 A 229 GLY LEU HIS ALA TRP GLN ILE ASN TRP PRO ALA ARG GLN SEQRES 9 A 229 ARG GLY THR HIS ALA VAL VAL GLY VAL ALA THR ALA ARG SEQRES 10 A 229 ALA PRO LEU HIS SER VAL GLY TYR THR ALA LEU VAL GLY SEQRES 11 A 229 SER ASP ALA GLU SER TRP GLY TRP ASP LEU GLY ARG SER SEQRES 12 A 229 ARG LEU TYR HIS ASP GLY LYS ASN GLN PRO GLY VAL ALA SEQRES 13 A 229 TYR PRO ALA PHE LEU GLY PRO ASP GLU ALA PHE ALA LEU SEQRES 14 A 229 PRO ASP SER LEU LEU VAL VAL LEU ASP MET ASP GLU GLY SEQRES 15 A 229 THR LEU SER PHE ILE VAL ASP GLY GLN TYR LEU GLY VAL SEQRES 16 A 229 ALA PHE ARG GLY LEU LYS GLY LYS LYS LEU TYR PRO VAL SEQRES 17 A 229 VAL SER ALA VAL TRP GLY HIS CYS GLU VAL THR MET ARG SEQRES 18 A 229 TYR ILE ASN GLY LEU ASP PRO GLU SEQRES 1 B 8 GZJ VAL ASP ILE ASN ASN ASN CY3 SEQRES 1 C 229 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 C 229 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLY ALA GLU SEQRES 3 C 229 PRO GLY ARG PRO ALA ARG LEU ASP GLN LEU LEU ASP MET SEQRES 4 C 229 PRO ALA ALA GLY LEU ALA VAL GLN LEU ARG HIS ALA TRP SEQRES 5 C 229 ASN PRO GLU ASP ARG SER LEU ASN VAL PHE VAL LYS ASP SEQRES 6 C 229 ASP ASP ARG LEU THR PHE HIS ARG HIS PRO VAL ALA GLN SEQRES 7 C 229 SER THR ASP GLY ILE ARG GLY LYS VAL GLY HIS ALA ARG SEQRES 8 C 229 GLY LEU HIS ALA TRP GLN ILE ASN TRP PRO ALA ARG GLN SEQRES 9 C 229 ARG GLY THR HIS ALA VAL VAL GLY VAL ALA THR ALA ARG SEQRES 10 C 229 ALA PRO LEU HIS SER VAL GLY TYR THR ALA LEU VAL GLY SEQRES 11 C 229 SER ASP ALA GLU SER TRP GLY TRP ASP LEU GLY ARG SER SEQRES 12 C 229 ARG LEU TYR HIS ASP GLY LYS ASN GLN PRO GLY VAL ALA SEQRES 13 C 229 TYR PRO ALA PHE LEU GLY PRO ASP GLU ALA PHE ALA LEU SEQRES 14 C 229 PRO ASP SER LEU LEU VAL VAL LEU ASP MET ASP GLU GLY SEQRES 15 C 229 THR LEU SER PHE ILE VAL ASP GLY GLN TYR LEU GLY VAL SEQRES 16 C 229 ALA PHE ARG GLY LEU LYS GLY LYS LYS LEU TYR PRO VAL SEQRES 17 C 229 VAL SER ALA VAL TRP GLY HIS CYS GLU VAL THR MET ARG SEQRES 18 C 229 TYR ILE ASN GLY LEU ASP PRO GLU SEQRES 1 D 8 GZJ VAL ASP ILE ASN ASN ASN CY3 SEQRES 1 E 229 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 E 229 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLY ALA GLU SEQRES 3 E 229 PRO GLY ARG PRO ALA ARG LEU ASP GLN LEU LEU ASP MET SEQRES 4 E 229 PRO ALA ALA GLY LEU ALA VAL GLN LEU ARG HIS ALA TRP SEQRES 5 E 229 ASN PRO GLU ASP ARG SER LEU ASN VAL PHE VAL LYS ASP SEQRES 6 E 229 ASP ASP ARG LEU THR PHE HIS ARG HIS PRO VAL ALA GLN SEQRES 7 E 229 SER THR ASP GLY ILE ARG GLY LYS VAL GLY HIS ALA ARG SEQRES 8 E 229 GLY LEU HIS ALA TRP GLN ILE ASN TRP PRO ALA ARG GLN SEQRES 9 E 229 ARG GLY THR HIS ALA VAL VAL GLY VAL ALA THR ALA ARG SEQRES 10 E 229 ALA PRO LEU HIS SER VAL GLY TYR THR ALA LEU VAL GLY SEQRES 11 E 229 SER ASP ALA GLU SER TRP GLY TRP ASP LEU GLY ARG SER SEQRES 12 E 229 ARG LEU TYR HIS ASP GLY LYS ASN GLN PRO GLY VAL ALA SEQRES 13 E 229 TYR PRO ALA PHE LEU GLY PRO ASP GLU ALA PHE ALA LEU SEQRES 14 E 229 PRO ASP SER LEU LEU VAL VAL LEU ASP MET ASP GLU GLY SEQRES 15 E 229 THR LEU SER PHE ILE VAL ASP GLY GLN TYR LEU GLY VAL SEQRES 16 E 229 ALA PHE ARG GLY LEU LYS GLY LYS LYS LEU TYR PRO VAL SEQRES 17 E 229 VAL SER ALA VAL TRP GLY HIS CYS GLU VAL THR MET ARG SEQRES 18 E 229 TYR ILE ASN GLY LEU ASP PRO GLU SEQRES 1 F 8 GZJ VAL ASP ILE ASN ASN ASN CY3 HET GZJ B 1 9 HET CY3 B 101 7 HET GZJ D 1 9 HET CY3 D 101 7 HET CY3 F 101 7 HET ACT A 301 4 HET SO4 A 302 5 HET ACT C 301 4 HET SO4 C 302 5 HET SO4 C 303 5 HET ACT E 301 4 HETNAM GZJ (2S)-2-(ACETYLAMINO)BUTANOIC ACID HETNAM CY3 2-AMINO-3-MERCAPTO-PROPIONAMIDE HETNAM ACT ACETATE ION HETNAM SO4 SULFATE ION FORMUL 2 GZJ 2(C6 H11 N O3) FORMUL 2 CY3 3(C3 H8 N2 O S) FORMUL 7 ACT 3(C2 H3 O2 1-) FORMUL 8 SO4 3(O4 S 2-) FORMUL 13 HOH *519(H2 O) HELIX 1 AA1 PRO A 34 ASP A 42 1 9 HELIX 2 AA2 GLY A 47 HIS A 54 1 8 HELIX 3 AA3 PRO A 105 ARG A 109 5 5 HELIX 4 AA4 ARG C 36 MET C 43 1 8 HELIX 5 AA5 GLY C 47 HIS C 54 1 8 HELIX 6 AA6 PRO C 105 ARG C 109 5 5 HELIX 7 AA7 PRO E 34 MET E 43 1 10 HELIX 8 AA8 GLY E 47 HIS E 54 1 8 HELIX 9 AA9 PRO E 105 ARG E 109 5 5 SHEET 1 AA1 3 TRP A 56 ARG A 61 0 SHEET 2 AA1 3 SER A 83 GLY A 89 -1 O ARG A 88 N ASN A 57 SHEET 3 AA1 3 HIS A 125 VAL A 127 -1 O SER A 126 N THR A 84 SHEET 1 AA2 7 TRP A 56 ARG A 61 0 SHEET 2 AA2 7 SER A 83 GLY A 89 -1 O ARG A 88 N ASN A 57 SHEET 3 AA2 7 TYR A 210 ALA A 215 -1 O ALA A 215 N ASP A 85 SHEET 4 AA2 7 VAL A 114 ALA A 118 -1 N ALA A 118 O TYR A 210 SHEET 5 AA2 7 SER A 139 ASP A 143 -1 O TRP A 142 N VAL A 115 SHEET 6 AA2 7 ARG A 148 HIS A 151 -1 O ARG A 148 N ASP A 143 SHEET 7 AA2 7 VAL A 159 ALA A 160 -1 O VAL A 159 N LEU A 149 SHEET 1 AA3 7 VAL A 65 LYS A 68 0 SHEET 2 AA3 7 ASP A 71 ARG A 77 -1 O THR A 74 N LYS A 68 SHEET 3 AA3 7 GLU A 221 LEU A 230 -1 O MET A 224 N LEU A 73 SHEET 4 AA3 7 LEU A 97 ASN A 103 -1 N GLN A 101 O ARG A 225 SHEET 5 AA3 7 SER A 176 ASP A 182 -1 O LEU A 177 N ILE A 102 SHEET 6 AA3 7 THR A 187 VAL A 192 -1 O THR A 187 N ASP A 182 SHEET 7 AA3 7 GLN A 195 PHE A 201 -1 O ALA A 200 N LEU A 188 SHEET 1 AA4 3 TRP C 56 ARG C 61 0 SHEET 2 AA4 3 SER C 83 GLY C 89 -1 O ARG C 88 N ASN C 57 SHEET 3 AA4 3 HIS C 125 VAL C 127 -1 O SER C 126 N THR C 84 SHEET 1 AA5 7 TRP C 56 ARG C 61 0 SHEET 2 AA5 7 SER C 83 GLY C 89 -1 O ARG C 88 N ASN C 57 SHEET 3 AA5 7 TYR C 210 ALA C 215 -1 O ALA C 215 N ASP C 85 SHEET 4 AA5 7 VAL C 114 ALA C 118 -1 N ALA C 118 O TYR C 210 SHEET 5 AA5 7 SER C 139 ASP C 143 -1 O TRP C 140 N VAL C 117 SHEET 6 AA5 7 ARG C 148 HIS C 151 -1 O ARG C 148 N ASP C 143 SHEET 7 AA5 7 VAL C 159 ALA C 160 -1 O VAL C 159 N LEU C 149 SHEET 1 AA610 VAL C 65 VAL C 67 0 SHEET 2 AA610 THR C 74 ARG C 77 -1 O HIS C 76 N PHE C 66 SHEET 3 AA610 GLU C 221 LEU C 230 -1 O VAL C 222 N PHE C 75 SHEET 4 AA610 LEU C 97 ASN C 103 -1 N GLN C 101 O ARG C 225 SHEET 5 AA610 SER C 176 ASP C 182 -1 O VAL C 179 N TRP C 100 SHEET 6 AA610 THR C 187 VAL C 192 -1 O SER C 189 N VAL C 180 SHEET 7 AA610 GLN C 195 PHE C 201 -1 O ALA C 200 N LEU C 188 SHEET 8 AA610 TRP E 56 SER E 62 -1 O ARG E 61 N TYR C 196 SHEET 9 AA610 SER E 83 GLY E 89 -1 O ARG E 88 N ASN E 57 SHEET 10 AA610 HIS E 125 VAL E 127 -1 O SER E 126 N THR E 84 SHEET 1 AA714 VAL C 65 VAL C 67 0 SHEET 2 AA714 THR C 74 ARG C 77 -1 O HIS C 76 N PHE C 66 SHEET 3 AA714 GLU C 221 LEU C 230 -1 O VAL C 222 N PHE C 75 SHEET 4 AA714 LEU C 97 ASN C 103 -1 N GLN C 101 O ARG C 225 SHEET 5 AA714 SER C 176 ASP C 182 -1 O VAL C 179 N TRP C 100 SHEET 6 AA714 THR C 187 VAL C 192 -1 O SER C 189 N VAL C 180 SHEET 7 AA714 GLN C 195 PHE C 201 -1 O ALA C 200 N LEU C 188 SHEET 8 AA714 TRP E 56 SER E 62 -1 O ARG E 61 N TYR C 196 SHEET 9 AA714 SER E 83 GLY E 89 -1 O ARG E 88 N ASN E 57 SHEET 10 AA714 TYR E 210 ALA E 215 -1 O ALA E 215 N ASP E 85 SHEET 11 AA714 VAL E 114 ALA E 118 -1 N ALA E 118 O TYR E 210 SHEET 12 AA714 SER E 139 ASP E 143 -1 O TRP E 142 N VAL E 115 SHEET 13 AA714 ARG E 148 TYR E 150 -1 O ARG E 148 N ASP E 143 SHEET 14 AA714 VAL E 159 ALA E 160 -1 O VAL E 159 N LEU E 149 SHEET 1 AA8 7 VAL E 65 VAL E 67 0 SHEET 2 AA8 7 THR E 74 ARG E 77 -1 O HIS E 76 N PHE E 66 SHEET 3 AA8 7 GLU E 221 LEU E 230 -1 O VAL E 222 N PHE E 75 SHEET 4 AA8 7 LEU E 97 ASN E 103 -1 N GLN E 101 O ARG E 225 SHEET 5 AA8 7 SER E 176 ASP E 182 -1 O VAL E 179 N TRP E 100 SHEET 6 AA8 7 THR E 187 VAL E 192 -1 O THR E 187 N ASP E 182 SHEET 7 AA8 7 GLN E 195 PHE E 201 -1 O ALA E 200 N LEU E 188 LINK C GZJ B 1 N VAL B 2 1555 1555 1.30 LINK CG GZJ B 1 SG CY3 B 101 1555 1555 1.69 LINK C ASN B 7 N CY3 B 101 1555 1555 1.41 LINK C GZJ D 1 N VAL D 2 1555 1555 1.35 LINK CG GZJ D 1 SG CY3 D 101 1555 1555 1.80 LINK C ASN D 7 N CY3 D 101 1555 1555 1.32 LINK C ASN F 7 N CY3 F 101 1555 1555 1.34 CISPEP 1 TYR A 161 PRO A 162 0 3.98 CISPEP 2 TYR C 161 PRO C 162 0 -0.63 CISPEP 3 TYR E 161 PRO E 162 0 -1.96 SITE 1 AC1 6 SER A 62 LEU A 63 HIS A 125 HOH A 449 SITE 2 AC1 6 GLN C 101 HOH C 437 SITE 1 AC2 5 ARG A 148 TYR A 150 PRO A 157 GLY A 158 SITE 2 AC2 5 LYS C 207 SITE 1 AC3 3 ARG C 121 LYS C 207 LYS C 208 SITE 1 AC4 3 ARG C 53 HIS C 54 HOH C 417 SITE 1 AC5 3 HIS C 76 HIS C 219 HOH C 484 SITE 1 AC6 3 VAL E 50 ARG E 53 HIS E 54 SITE 1 AC7 4 GLU A 185 VAL B 2 ASP B 3 ASN B 7 SITE 1 AC8 6 ASP D 3 ILE D 4 ASN D 6 CY3 D 101 SITE 2 AC8 6 HOH D 202 HOH D 205 SITE 1 AC9 17 ASP A 231 ARG C 77 PRO C 79 VAL C 80 SITE 2 AC9 17 ALA C 81 TYR C 129 VAL C 216 GLY C 218 SITE 3 AC9 17 HOH C 474 HOH C 491 GZJ D 1 VAL D 2 SITE 4 AC9 17 ASP D 3 ASN D 5 ASN D 6 HOH D 204 SITE 5 AC9 17 HOH D 207 SITE 1 AD1 10 ASP A 231 HOH C 474 HOH C 491 VAL D 2 SITE 2 AD1 10 ASP D 3 ILE D 4 ASN D 6 ASN D 7 SITE 3 AD1 10 HOH D 202 HOH D 204 SITE 1 AD2 14 ARG E 77 PRO E 79 VAL E 80 ALA E 81 SITE 2 AD2 14 TYR E 129 VAL E 216 GLY E 218 HOH E 479 SITE 3 AD2 14 VAL F 2 ASP F 3 ASN F 5 ASN F 6 SITE 4 AD2 14 HOH F 201 HOH F 202 CRYST1 49.020 109.370 118.100 90.00 90.00 90.00 P 2 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020400 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009143 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008467 0.00000